These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4141158)

  • 1. [Influence of gestonoron-capronate (GC) upon uptake and metabolism of H3-testosteron in benign prostatic hypertrophy (BPH): in vivo-experiments (author's transl)].
    Orestano F; Bandhauer K; Altwein JE
    Urologe A; 1974 Nov; 13(6):289-92. PubMed ID: 4141158
    [No Abstract]   [Full Text] [Related]  

  • 2. Testosterone metabolism in benign prostatic hypertrophy. Suppression by diethylstilbestrol and gestonorone capronate.
    Orestano F; Klose K; Rubin A; Knapstein P; Altwein JE
    Invest Urol; 1974 Sep; 12(2):151-6. PubMed ID: 4137236
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of estradiol, diethylstilbestrol, progesterone, and gestonorone capronate (depostat) on the 5 alpha-reductase kinetics in benign prostatic hypertrophy (BPH) (author's transl)].
    Altwein JE; Rubin A; Klose K; Knapstein P; Orestano F
    Urologe A; 1974 Jan; 13(1):41-6. PubMed ID: 4132876
    [No Abstract]   [Full Text] [Related]  

  • 4. Testosterone metabolism in benign prostatic hypertrophy: in vivo studies of gestonorone caproate and cyproterone acetate.
    Orestano F; Altwein JE
    Br J Urol; 1976 Dec; 48(6):485-91. PubMed ID: 64267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone metabolism in human prostatic tissue and blood in patients with benign prostatic hypertrophy (BPH).
    Becker H; Buric L; Petersen C; Voigt KD
    Acta Endocrinol Suppl (Copenh); 1971; 152():28. PubMed ID: 4101325
    [No Abstract]   [Full Text] [Related]  

  • 6. Mode of action of progesterone, gestonorone capronate (Depostat) and cyproterone acetate (Androcur) on the metabolism of testosterone in human prostatic adenoma: in vitro and in vivo investigations.
    Orestano F; Altwein JE; Knapstein P; Bandhauer K
    J Steroid Biochem; 1975 Jun; 6(6):845-51. PubMed ID: 1177428
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recent results of prostatic adenoma research].
    Kaufmann J
    Z Urol Nephrol; 1975 Nov; 68(11):. PubMed ID: 58501
    [No Abstract]   [Full Text] [Related]  

  • 8. Preliminary report on the effect of gestonorone capronate on human prostate LDH-isoenzymes.
    Govaerts J; van Sande M; Van Camp K
    Acta Urol Belg; 1978; 46(4):389-92. PubMed ID: 83788
    [No Abstract]   [Full Text] [Related]  

  • 9. Progestagen action on testosterone uptake and metabolism in the rat prostate.
    Smethurst M; Williams DC
    IRCS J Med Sci; 1975 Oct; 3(10):491. PubMed ID: 1165169
    [No Abstract]   [Full Text] [Related]  

  • 10. [Metabolism of 3H-testosteron and 3H-5alpha-DHT in the normal and adenomatous prostate (author's transl)].
    Becker H; Klosterhalfen H; Voigt KD
    Urol Int; 1973; 28(3):350-5. PubMed ID: 4127746
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo uptake and metabolism of 3H-testosterone and 3H-5 -dihydrotestosterone by human benign prostatic hypertrophy.
    Becker H; Kaufmann J; Klosterhalfen H; Voigt KD
    Acta Endocrinol (Copenh); 1972 Nov; 71(3):589-99. PubMed ID: 4117573
    [No Abstract]   [Full Text] [Related]  

  • 12. Testosterone turnover in cancer of the prostate: suppression by gestagens in vitro.
    Altwein JE; Orestano F; Hohenfellner R
    Invest Urol; 1974 Sep; 12(2):157-61. PubMed ID: 4854628
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of benign prostatic hypertrophy with gestonorone caproate].
    Baranowska B; Kuzaka B
    Pol Tyg Lek; 1984 Jul 16-23; 39(29-30):999-1003. PubMed ID: 6209689
    [No Abstract]   [Full Text] [Related]  

  • 14. The influence of the progestogen gestonorone caproate on testosterone turnover in renal cell carcinoma. An in vitro study.
    Marberger M; Altwein JE; Orestano F
    Invest Urol; 1976 Jan; 13(4):302-6. PubMed ID: 1245393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of stilbestrol on the metabolism of testosterone by benign prostatic hyperplasia in organ culture.
    McMahon MJ; Thomas GH
    Br J Surg; 1971 Nov; 58(11):869. PubMed ID: 4108125
    [No Abstract]   [Full Text] [Related]  

  • 16. [Measurement of T and DHT contents in normal and diseased human prostate tissues].
    Zhang Y; Ye L; Ding Q; Fang Z; Yao M; Shi D
    Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):545-7. PubMed ID: 11832106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endocrinological principles of conservative therapy for prostatic adenoma].
    Altwein JE; Orestano F
    Dtsch Med Wochenschr; 1975 Mar; 100(12):626-9. PubMed ID: 47287
    [No Abstract]   [Full Text] [Related]  

  • 18. Secretion of dihydrotestosterone by human prostate in benign prostatic hypertrophy.
    Mahoudeau JA; Delassalle A; Bricaire H
    Acta Endocrinol (Copenh); 1974 Oct; 77(2):401-7. PubMed ID: 4138446
    [No Abstract]   [Full Text] [Related]  

  • 19. A direct effect of estrogens on prostatic metabolism of testosterone.
    Farnsworth WE
    Invest Urol; 1969 Jan; 6(4):423-7. PubMed ID: 4180068
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results of treating prostatic adenoma with Depostat].
    Darenkov AF; Zakhvatov IuM; Tanko A; Ignashin NS; Varentsov GI
    Urol Nefrol (Mosk); 1980; (5):34-7. PubMed ID: 6158780
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.